Therapeutic effects of rituximab combined with cyclophosphamide on refractory idiopathic thrombocytopenic purpura

Therapeutic effects of rituximab combined with cyclophosphamide on refractory idiopathic thrombocytopenic purpura (ITP) were investigated. We retrospectively analyzed 249 patients with refractory ITP who were admitted to Qingdao Hiser Medical Group between March 2013 and March 2017. Curative effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiuhe, Wang, Bin, Sun, Zhonghui, Xue, Kezeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395969/
https://www.ncbi.nlm.nih.gov/pubmed/30867701
http://dx.doi.org/10.3892/etm.2019.7196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395969/
https://www.ncbi.nlm.nih.gov/pubmed/30867701
http://dx.doi.org/10.3892/etm.2019.7196

Ejemplares similares